EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 -0.7214
March 31, 2026 -0.9501
December 31, 2025 -1.121
September 30, 2025 -1.202
June 30, 2025 -1.227
March 31, 2025 -1.234
December 31, 2024 -1.298
September 30, 2024 -1.496
June 30, 2024 -1.683
March 31, 2024 -1.816
December 31, 2023 -1.894
September 30, 2023 -2.079
June 30, 2023 -2.247
March 31, 2023 -2.404
December 31, 2022 -2.485
September 30, 2022 -2.479
June 30, 2022 -2.402
March 31, 2022 -2.299
December 31, 2021 -2.228
September 30, 2021 -2.061
June 30, 2021 -1.907
March 31, 2021 -1.851
December 31, 2020 -1.889
September 30, 2020 -1.926
June 30, 2020 -1.926
Date Value
March 31, 2020 -1.837
December 31, 2019 -1.587
September 30, 2019 -1.357
June 30, 2019 -1.314
March 31, 2019 -1.269
December 31, 2018 -1.284
September 30, 2018 -1.370
June 30, 2018 -1.364
March 31, 2018 -1.394
December 31, 2017 -1.41
September 30, 2017 -1.30
June 30, 2017 -2.10
March 31, 2017 -1.96
December 31, 2016 -1.77
September 30, 2016 -1.72
June 30, 2016 -0.73
March 31, 2016 -0.64
December 31, 2015 -0.64
September 30, 2015 -0.5842
June 30, 2015 -0.5342
March 31, 2015 -0.4842
December 31, 2014 -0.4542
September 30, 2014 -1.81
June 30, 2014 -2.36
March 31, 2014 -57.21

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
AVITA Medical, Inc. -1.444
Halozyme Therapeutics, Inc. 3.347
Amgen, Inc. 16.10
CareDx, Inc. 2.075
Xencor, Inc. -2.170